The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux
Open accessAbstract
Background and aims: While patients with Barrett’s oesophagus develop oesophageal adenocarcinoma more frequently than the general population, it has controversially been suggested that gastro-oesophageal reflux (GORD) itself is a more important determinant of risk. In order to assess the validity of this suggestion, we examined the risk of oesophageal cancer in patients with Barrett’s and with GORD compared with the general population in a community based cohort study. Methods: Cohorts of patients with Barrett’s (n = 1677), oesophagitis (n = 6392), and simple reflux (n = 6328), and a reference cohort (n = 13416) were selected from the General Practice Research Database. The last three cohorts were matched to the Barrett’s cohort by general practitioner practice, age, and sex. Cox’s regression analysis was used to calculate relative risks for oesophageal cancer. Standardised incidence ratio methodology was used to estimate the relative risks for oesophageal adenocarcinoma. Results: A total of 137 oesophageal cancers were identified, of which 94 prevalent cases were excluded. The hazard ratios for oesophageal cancer were 10.6 (5.1–22.0), 2.2 (0.9–5.2), and 1.7 (0.7–4.5) in the Barrett’s, oesophagitis, and reflux cohorts compared with the reference cohort, respectively. The corresponding relative risks for oesophageal adenocarcinoma were 29.8 (9.6–106), 4.5 (1.04–19.6), and 3.1 (0.6–14.2). Conclusion: Barrett’s oesophagus increases the risk of oesophageal cancer approximately 10 times and oesophageal adenocarcinoma approximately 30 times compared with the general population. There is only a modestly increased risk of oesophageal cancer in patients with reflux who have no record of Barrett’s oesophagus. Our findings therefore do not support the suggestion that gastro-oesophageal reflux disease itself predisposes to cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Barrett's Esophagus; Development of Dysplasia and Adenocarcinoma
Hameeteman, W., Tytgat, G. N. J., Houthoff, H. J., & van den Tweel, J. G. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80011-3 · Cited by 859
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
Shaheen, N. J., Crosby, M. A., Bozymski, E. M., & Sandler, R. S. (2000) · Gastroenterology · doi:10.1053/gast.2000.9302 · Cited by 758
The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) Esophagus
Cameron, A. J., Ott, B. J., & Payne, W. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131404 · Cited by 715
The UK General Practice Research Database
Walley, T., & Mantgani, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04248-7 · Cited by 623
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
Botterweck, A. A., Schouten, L. J., Volovics, A., Dorant, E., & van den Brandt, P. A. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.645 · Cited by 537
Ricketts, R. R. (1998) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(98)90392-x · Cited by 452
Adenocarcinoma and Barrett's esophagus. An overrated risk?
Spechler, S. J., Robbins, A. H., Rubins, H. B., et al. (1984) · PubMed · Cited by 437
O'Connor, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00331-7 · Cited by 357
Drewitz, D. J., Sampliner, R. E., & Garewal, H. S. (1997) · PubMed · Cited by 315
Cited by
Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., Jones, R., & the Global Consensus Group (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00630.x · Cited by 3,924
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Incidence of Adenocarcinoma among Patients with Barrett's Esophagus
Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sørensen, H. T., & Funch-Jensen, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103042 · Cited by 1,371
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
Desai, T. K., Krishnan, K., Samala, N., Singh, J., Cluley, J., Perla, S., & Howden, C. W. (2012) · Gut · doi:10.1136/gutjnl-2011-300730 · Cited by 609
Metadata
- Authors
- Solaymani-Dodaran, M., Logan, R. F. A., West, J., Card, T., & Coupland, C.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-07-09
- Volume
- 53
- Issue
- 8
- Pages
- 1070-1074
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2100503989
- Cited by
- 280
- References
- 21
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. https://app.cochat.ai/papers/10.1136/gut.2003.028076
- The paper
- Solaymani-Dodaran, M., Logan, R. F. A., West, J., Card, T., & Coupland, C. (2004). Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. Gut. https://doi.org/10.1136/gut.2003.028076
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.